Guy Fagherazzi1, Gaëlle Gusto, Françoise Clavel-Chapelon, Beverley Balkau, Fabrice Bonnet. 1. Team 9, Nutrition, Hormones and Women's Health, Inserm U1018, Centre for Research in Epidemiology and Population Health, Gustave Roussy Institute, 114 rue Edouard Vaillant, 94805, Villejuif Cedex, France, guy.fagherazzi@gustaveroussy.fr.
Abstract
AIMS/HYPOTHESIS: The objective of this study was to evaluate the relationship of ABO blood type (A, B, AB and O), Rhesus factor (positive or negative) and a combination of the two (ABO × Rhesus) with type 2 diabetes mellitus risk. METHODS: In total, 82,104 women from the large prospective E3N cohort were followed between 1990 and 2008. Multivariate Cox regression models were used to estimate HRs and 95% CIs. RESULTS: Those with either the A (HR 1.10 [95% CI 1.02, 1.18]) or B (HR 1.21 [95% CI 1.07, 1.36]) group were at increased risk of type 2 diabetes mellitus compared with those with the O group. The association with the AB group did not reach statistical significance (HR 1.17 [95% CI 0.99, 1.39]). There was no difference in type 2 diabetes mellitus risk between Rhesus positive and negative groups (HR 0.96 [95% CI 0.88, 1.05]). When the universal donors (O(-)) were taken as the reference category, we observed an increased risk for both A(+) (HR 1.17 [95% CI 1.02, 1.35]) and A(-) (HR 1.22 [95% CI 1.03, 1.45]) individuals. The greatest increase in risk was seen for those with the B(+) blood group (HR 1.35 [95% CI 1.13, 1.60]). We also observed a greater type 2 diabetes mellitus risk for those with the AB(+) group (HR 1.26 [95% CI 1.02, 1.57]). Adjustment for fasting plasma glucose and lipid concentrations in a case-control subsample did not alter the associations. CONCLUSIONS/ INTERPRETATION: This study suggests that people with the O blood type have a lower risk of developing type 2 diabetes mellitus. Therefore, blood group should be investigated in future clinical and epidemiological studies on diabetes, and further pathophysiological research is needed to determine why individuals with blood type O have a lower risk of type 2 diabetes mellitus.
AIMS/HYPOTHESIS: The objective of this study was to evaluate the relationship of ABO blood type (A, B, AB and O), Rhesus factor (positive or negative) and a combination of the two (ABO × Rhesus) with type 2 diabetes mellitus risk. METHODS: In total, 82,104 women from the large prospective E3N cohort were followed between 1990 and 2008. Multivariate Cox regression models were used to estimate HRs and 95% CIs. RESULTS: Those with either the A (HR 1.10 [95% CI 1.02, 1.18]) or B (HR 1.21 [95% CI 1.07, 1.36]) group were at increased risk of type 2 diabetes mellitus compared with those with the O group. The association with the AB group did not reach statistical significance (HR 1.17 [95% CI 0.99, 1.39]). There was no difference in type 2 diabetes mellitus risk between Rhesus positive and negative groups (HR 0.96 [95% CI 0.88, 1.05]). When the universal donors (O(-)) were taken as the reference category, we observed an increased risk for both A(+) (HR 1.17 [95% CI 1.02, 1.35]) and A(-) (HR 1.22 [95% CI 1.03, 1.45]) individuals. The greatest increase in risk was seen for those with the B(+) blood group (HR 1.35 [95% CI 1.13, 1.60]). We also observed a greater type 2 diabetes mellitus risk for those with the AB(+) group (HR 1.26 [95% CI 1.02, 1.57]). Adjustment for fasting plasma glucose and lipid concentrations in a case-control subsample did not alter the associations. CONCLUSIONS/ INTERPRETATION: This study suggests that people with the O blood type have a lower risk of developing type 2 diabetes mellitus. Therefore, blood group should be investigated in future clinical and epidemiological studies on diabetes, and further pathophysiological research is needed to determine why individuals with blood type O have a lower risk of type 2 diabetes mellitus.
Authors: Meian He; Brian Wolpin; Kathy Rexrode; Joann E Manson; Eric Rimm; Frank B Hu; Lu Qi Journal: Arterioscler Thromb Vasc Biol Date: 2012-08-14 Impact factor: 8.311
Authors: Maja Barbalic; Josée Dupuis; Abbas Dehghan; Joshua C Bis; Ron C Hoogeveen; Renate B Schnabel; Vijay Nambi; Monique Bretler; Nicholas L Smith; Annette Peters; Chen Lu; Russell P Tracy; Nena Aleksic; Jan Heeriga; John F Keaney; Kenneth Rice; Gregory Y H Lip; Ramachandran S Vasan; Nicole L Glazer; Martin G Larson; Andre G Uitterlinden; Jennifer Yamamoto; Peter Durda; Talin Haritunians; Bruce M Psaty; Eric Boerwinkle; Albert Hofman; Wolfgang Koenig; Nancy S Jenny; Jacqueline C Witteman; Christie Ballantyne; Emelia J Benjamin Journal: Hum Mol Genet Date: 2010-02-18 Impact factor: 6.150
Authors: Harri Mäkivuokko; Sampo J Lahtinen; Pirjo Wacklin; Elina Tuovinen; Heli Tenkanen; Janne Nikkilä; Marika Björklund; Kari Aranko; Arthur C Ouwehand; Jaana Mättö Journal: BMC Microbiol Date: 2012-06-06 Impact factor: 3.605
Authors: Giuseppe Lippi; Giorgio Gandini; Gian Luca Salvagno; Spyros Skafidas; Luca Festa; Elisa Danese; Martina Montagnana; Fabian Sanchis-Gomar; Cantor Tarperi; Federico Schena Journal: Ann Transl Med Date: 2017-06
Authors: M Lemaitre; M Passet; L Ghesquière; C Martin; E Drumez; D Subtil; A Vambergue Journal: Front Endocrinol (Lausanne) Date: 2022-06-22 Impact factor: 6.055
Authors: Artika P Nath; Scott C Ritchie; Nastasiya F Grinberg; Howard Ho-Fung Tang; Qin Qin Huang; Shu Mei Teo; Ari V Ahola-Olli; Peter Würtz; Aki S Havulinna; Kristiina Santalahti; Niina Pitkänen; Terho Lehtimäki; Mika Kähönen; Leo-Pekka Lyytikäinen; Emma Raitoharju; Ilkka Seppälä; Antti-Pekka Sarin; Samuli Ripatti; Aarno Palotie; Markus Perola; Jorma S Viikari; Sirpa Jalkanen; Mikael Maksimow; Marko Salmi; Chris Wallace; Olli T Raitakari; Veikko Salomaa; Gad Abraham; Johannes Kettunen; Michael Inouye Journal: Am J Hum Genet Date: 2019-10-31 Impact factor: 11.025